Clinical Science — World Parkinson Congress Blog

Posts in Clinical Science

Helping Caregivers Learn to Persevere

Helping Caregivers Learn to Persevere

by Jori Fleisher, MD MSCE FAAN

Living with Parkinson's, Comprehensive Living, Clinical ScienceJori Fleisher, MD MSCE FAANDecember 6, 2024Nine, Parkinson's, Care giver, Peer mentor, Education, Peer Support, randomized controlled trial, NIH, Lewy BodyComment

In Your Own Words: Fears and Uncertainties in Parkinson's Disease

In Your Own Words: Fears and Uncertainties in Parkinson's Disease

by Sneha Mantri, MD MS

Clinical ScienceSneha Mantri, MD MSJune 19, 2024Nine, Parkinson's, WPC2023Comment

Talk the Walk: Dual Tasking With Walking And Visual-Verbal Processing

Talk the Walk: Dual Tasking With Walking And Visual-Verbal Processing

by Valerie Carter PT, DPT, NCS, GCS

Clinical ScienceValerie Carter PT, DPT, NCS, GCSJune 5, 2024Nine, Parkinson's, Walking, WPC2023Comment

From Canada to Barcelona: Bringing the Canadian Open Parkinson Network (C-OPN) to the 6th World Parkinson Congress

From Canada to Barcelona: Bringing the Canadian Open Parkinson Network (C-OPN) to the 6th World Parkinson Congress

by Marisa Cressatti, PhD

Advocacy, Clinical ScienceMarisa Cressatti, PhDMay 23, 2024parkinsons, Nine, Atypical Parkinsonism, WPC2023, researchComment

Investigating Pain Catastrophizing To Improve Treatment Of Pain And Psychological Distress in Parkinson’s Disease

Investigating Pain Catastrophizing To Improve Treatment Of Pain And Psychological Distress in Parkinson’s Disease

by Sylvia Zimmers, PhD

Clinical ScienceSylvia Zimmers, PhDMay 9, 2024Parkinson's, WPC2023, Pain, anxiety, Depression, Catastrophizing, NineComment

Dyskinesia and Parkinson’s Disease

Dyskinesia and Parkinson’s Disease

by Tyler Okelberry, MD and Rajesh Pahwa, MD

Clinical ScienceTyler Okelberry, MD and Rajesh Pahwa, MDApril 5, 2024Parkinson's, Dyskinesia, WPC2023, Nine, LevodopaComment

Pre-Clinical Models of Levodopa - Induced Dyskinesia

Pre-Clinical Models of Levodopa - Induced Dyskinesia

by Philippe Huot, MD, PhD

Clinical SciencePhilippe Huot, MD, PhDFebruary 14, 2024Parkinson's, Levodopa, dysphagia, Nine Comment

The Role of Physical Therapy in the Management of Parkinson Disease

The Role of Physical Therapy in the Management of Parkinson Disease

by Katherine Marita, DPT

Clinical Science, Comprehensive LivingKatherine Marita, DPTDecember 6, 2023Physical therapy, Physical therapist, Physiotherapist, Rehabilitation, Exercise, Mobility, Movement, Walking, eightComment

Proactive Integrated Management and Empowerment in Parkinson’s

Proactive Integrated Management and Empowerment in Parkinson’s

by Dr Katie Lloyd MBChB MRCP (UK) BSc

Clinical ScienceDr Katie Lloyd MBChB MRCP BScNovember 20, 2023parkinsons, Health Care, Care Models, Clinical Trials, Process evaluation, Eight Comments

NLX-112: a First-in-Class, Dual-Acting, Non-Dopaminergic, Drug Candidate for Treatment of Parkinson’s Disease

NLX-112: a First-in-Class, Dual-Acting, Non-Dopaminergic, Drug Candidate for Treatment of Parkinson’s Disease

by Adrian Newman-Tancredi, PhD, DSc

Clinical ScienceAdrian Newman-Tancredi, PhD, DScAugust 14, 2023Eight, WPC2023, clinical research, levodopa-induced dyskinesia, serotonin, parkinsonism, 5 HT1A receptor Comments

Update on Prodromal Parkinson’s

Update on Prodromal Parkinson’s

by Michele Hu, PhD, MBBS, FRCP

Clinical ScienceMichele Hu, PhD, MBBS, FRCPApril 21, 2023REM sleep behavior disorder, Prodromal Parkinson’s, Parkinson's, WPC2023, eightComment

What’s synuclein, got to do, got to do with it…

What’s synuclein, got to do, got to do with it…

by Laura Volpicelli-Daley, PhD

Clinical ScienceLaura Volpicelli-Daley, PhDMarch 16, 2023Parkinson's, WPC2023, Eight, Cognition Comments

Participating in Research Studies: Myths and Legends

Participating in Research Studies: Myths and Legends

by Ignacio F. Mata PhD

Clinical ScienceIgnacio F. Mata PhDMarch 13, 2023Parkinson's, research, WPC2023, eightComment

COVID-19 and Parkinson’s Disease

COVID-19 and Parkinson’s Disease

by Alfonso Fasano, MD, PhD, FAAN

Clinical ScienceAlfonso Fasano, MD, PhD, FAANFebruary 23, 2023Parkinson's, COVID-19, acute respiratory syndrome coronavirus 2, eightComment

The Importance of Modeling Peripheral Nervous System Dysfunction and Old Age in Parkinson’s Disease

The Importance of Modeling Peripheral Nervous System Dysfunction and Old Age in Parkinson’s Disease

by Nathalie Van Den Berge

Clinical ScienceNathalie Van Den BergeFebruary 9, 2023Parkinson's, nervous system, peripheral, EightComment

What Are the Gene Therapy and Growth Factor Approaches for Parkinson’s Disease?

What Are the Gene Therapy and Growth Factor Approaches for Parkinson’s Disease?

by Krystof S. Bankiewicz, MD, PhD

Clinical ScienceKrystof S. Bankiewicz, MD, PhDFebruary 2, 2023Parkinson's Disease, Gene Therapy, Advanced Therapeutics, Growth Factors, GDNF, AAV, Neurosurgical Delivery, AskBio, EightComment

Parkinson's: When Anxiety Becomes A Central Symptom Of The Disease

Parkinson's: When Anxiety Becomes A Central Symptom Of The Disease

by Kathy Dujardin, PhD

Clinical ScienceKathy Dujardin, PhDJanuary 19, 2023Parkinson's, anxiety, WPC2023, Symptoms, Eight Comment

Radical Collaboration, Exercise, Neuroplasticity and Parkinson’s Disease

Radical Collaboration, Exercise, Neuroplasticity and Parkinson’s Disease

by Mark A. Hirsch, PhD, FACRM

Clinical ScienceMark A. Hirsch, PhDDecember 15, 2022Parkinson's, exercise, self-management, neuroplasticity, brain-derived neurotrophic factor, collaboration, wpc2023, Seven Comments

Personalized DBS Targeting: What You Need to Know

Personalized DBS Targeting: What You Need to Know

by Vanessa Milanese, MD, PhD

Clinical ScienceVanessa Milanese, MD, PhDOctober 6, 2022Seven, Parkinson's, Deep Brain Stimulation, Quality of Life, neuromodulation, functional neurosurgery Comment

Diagnostic Challenges and Pitfalls in Parkinson’s Disease

Diagnostic Challenges and Pitfalls in Parkinson’s Disease

by Oscar S. Gershanik, MD

Clinical ScienceOscar S. Gershanik MDJuly 25, 2022Parkinson's, SevenComment